UGT1A1 and Hyperbilirubinemia: Previously, using a candidate gene approach, Kishi et al3 identified the UGT1A1 promoter TA repeat variant (rs8175347) as associated with hyperbilirubinemia during all treatment phases in a single-institution study at St Jude Children’s Research Hospital (Total XIIIB protocol).